66224-70-2Relevant articles and documents
Synthesis of unstable carbides Ag2C2n (n = 3, 4) and characterization via crystallographic analysis of their double salts with silver(I) trifluoroacetate
Hau, Sam C. K.,Mak, Thomas C. W.
, p. 902 - 905 (2014)
Two new silver(I) carbides, Ag2C6 and Ag 2C8, have been synthesized, and single-crystal X-ray analysis of their crystalline silver(I) trifluoroacetate complexes, Ag 2C6·8AgCF3CO2·6H 2O, 4(Ag2C6)·16AgCF3CO 2·14.5DMSO, and 2.5(Ag2C8) ·10AgCF3CO2·10DMSO, provides detailed information on the influence of ligand disposition and orientation of the all-carbon anionic ligands in the construction of multidimensional supramolecular structures, which are consolidated by argentophilic and weak inter-/intramolecular interactions.
One-pot synthesis of 3-(trimethylsilyl)propynamides
Medvedeva,Andreev,Safronova
, p. 1466 - 1470 (2010)
A highly efficient one-pot procedure was developed for the synthesis of 3-trimethylsilylpropynamides by acylation of amines with trimethylsilylpropynoyl chloride generated in situ. Selective N-acylation and N,O-bis-acylation of -amino alcohols with format
COMPOUNDS AND METHODS OF USE
-
Page/Page column 195; 197, (2022/03/09)
Disclosed are heterocyclic compounds or their pharmaceutically acceptable salts with ferroptosis-inducing activity, Those compounds or their pharmaceutically acceptable salts can be used to treat cancer.
CATHEPSIN C INHIBITORS
-
Paragraph 0171-0174, (2020/01/24)
Disclosed are compounds, pharmaceutical compositions used for inhibiting cathepsin C without inhibiting epidermal growth factor receptor (EGFR).
INHIBITORS OF RAC1 AND USES THEREOF FOR TREATING CANCERS
-
Paragraph 0113-0115, (2019/01/04)
The present invention concerns a compound having the following formula (I): wherein: - A is in particular -N(R'a)-C(=O)-R, R'a being H or a (C1-C6)alkyl group, and R being preferably a group having the following formula (II): - X is in particular chosen from the group consisting of: -SO2-N(R'b)-, R'b being H or a (C1-C6)alkyl group, -N(R"b)-SO2-, R"b being H or a (C1-C6)alkyl group, -CO-NH-, and -NH-CO-, for use for the treatment of cancers, such as metastatic cancers.
